Mannessier L, Dufossé F, Dehaut H, Goudemand M
Rev Fr Transfus Immunohematol. 1983 Nov;26(5):487-501. doi: 10.1016/s0338-4535(83)80119-6.
During the last four years, 118 blood donors have been immunized to obtain plasma with a high level anti-D in order to prepare anti-D immunoglobulins. The results of the immunizing schedule are very successful, as we have obtained anti-D of titer superior to 256 in 96,36% of the cases (Coombs technic). However, the development of unwanted antibodies outside the Rh system (anti-Jka: 6, anti-Fya: 5) has led us since November 1979 to use phenotyped blood without undesirable red blood cell antigens. No irregular antibody has developed since except for an anti-Yta. The anti-HLA have been observed with a frequency of 36%. The use of frozen/thawed and phenotyped blood without undesirable red blood cell antigens can allow to obtain a high level of anti-D without risk for the donors. Nevertheless, the exceptional immunization to a public antigen persists.
在过去四年中,为制备抗-D免疫球蛋白,对118名献血者进行了免疫以获取具有高滴度抗-D的血浆。免疫方案的结果非常成功,因为在96.36%的病例中(库姆斯技术)我们获得了效价高于256的抗-D。然而,自1979年11月以来,Rh系统以外不想要的抗体(抗-Jka:6例,抗-Fya:5例)的出现促使我们使用无不良红细胞抗原的表型血液。自那以后,除了一例抗-Yta外,未再出现不规则抗体。抗-HLA的出现频率为36%。使用冷冻/解冻且无不良红细胞抗原的表型血液可以在不危及献血者的情况下获得高滴度的抗-D。尽管如此,针对公共抗原的特殊免疫情况仍然存在。